In focus · trending topic

TSX-V:ZOM

18 stories · following the connections

Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform

By Nasdaq OMXDec 21, 2017, 11:55 AM UTC

Zomedica Announces Achievement of Therapeutic Development Milestones

By Nasdaq OMXDec 12, 2017, 11:55 AM UTC

Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission

By Nasdaq OMXNov 20, 2017, 11:51 PM UTC

Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

By Nasdaq OMXNov 16, 2017, 2:12 PM UTC

Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval

By Nasdaq OMXNov 10, 2017, 11:55 AM UTC

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

By Nasdaq OMXNov 9, 2017, 9:01 PM UTC

Zomedica Pharmaceuticals Corp. to Present at Jefferies 2017 London Healthcare Conference and LD Micro Main Event 2017

By Nasdaq OMXNov 8, 2017, 11:55 AM UTC

Zomedica Pharmaceuticals Corp. Announces US$5M Unsecured Working Capital Loan Facility

By Nasdaq OMXOct 18, 2017, 8:15 PM UTC